Shimadzu will distribute Marconi Medical Systems’ multislice CT products in Japan, while continuing to market its own CT product line. The two companies also signed a two-year extension of their agreement that has Shimadzu distributing
Shimadzu will distribute Marconi Medical Systems multislice CT products in Japan, while continuing to market its own CT product line. The two companies also signed a two-year extension of their agreement that has Shimadzu distributing Marconis nuclear medicine systems in Japan.
Although Shimadzu will market and distribute the products, they will be labeled with the Marconi name.
The relationship began 10 years ago when Marconi was known as Picker International. Last year, Shimadzu added Marconi MR systems to its own product line, which includes x-ray, CT, MRI, and ultrasound systems.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.